RUA Life Sciences (GB:RUA) has released an update.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
RUA Life Sciences has strategically expanded its contract manufacturing business with the acquisition of Analytic Biosurgical Solutions SAS (Abiss), a company specializing in implantable medical devices, for €80,000. Abiss, which was not in liquidation despite its parent company’s insolvency, has a strong track record with innovative surgical implants, owns intellectual property rights, and has a growing contract manufacture business. This acquisition is set to bolster RUA’s medium-term growth targets and complements its existing customer relationships and reputation for quality in the medical device sector.
For further insights into GB:RUA stock, check out TipRanks’ Stock Analysis page.